Chemoselective and Site‐Selective Lysine‐Directed Lysine Modification Enables Single‐Site Labeling of Native Proteins
The necessity for precision labeling of proteins emerged during the efforts to understand and regulate their structure and function. It demands selective attachment of tags such as affinity probes, fluorophores, and potent cytotoxins. Here, we report a method that enables single‐site labeling of a h...
Gespeichert in:
Veröffentlicht in: | Angewandte Chemie International Edition 2020-06, Vol.59 (26), p.10332-10336 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 10336 |
---|---|
container_issue | 26 |
container_start_page | 10332 |
container_title | Angewandte Chemie International Edition |
container_volume | 59 |
creator | Adusumalli, Srinivasa Rao Rawale, Dattatraya Gautam Thakur, Kalyani Purushottam, Landa Reddy, Neelesh C. Kalra, Neetu Shukla, Sanjeev Rai, Vishal |
description | The necessity for precision labeling of proteins emerged during the efforts to understand and regulate their structure and function. It demands selective attachment of tags such as affinity probes, fluorophores, and potent cytotoxins. Here, we report a method that enables single‐site labeling of a high‐frequency Lys residue in the native proteins. At first, the enabling reagent forms stabilized imines with multiple solvent‐accessible Lys residues chemoselectively. These linchpins create the opportunity to regulate the position of a second Lys‐selective electrophile connected by a spacer. Consequently, it enables the irreversible single‐site labeling of a Lys residue independent of its place in the reactivity order. The user‐friendly protocol involves a series of steps to deconvolute and address chemoselectivity, site‐selectivity, and modularity. Also, it delivers ordered immobilization and analytically pure probe‐tagged proteins. Besides, the methodology provides access to antibody‐drug conjugate (ADC), which exhibits highly selective anti‐proliferative activity towards HER‐2 expressing SKBR‐3 breast cancer cells.
A chemical methodology finally addresses the undefeated challenge of modular and precision engineering of a Lys residue in a native protein. The remarkable control over selectivity provides the first‐ever approach to target Lys beyond the protein‐defined reactivity hotspot. This technology unfolds new gateways and renders analytically pure protein bioconjugates and homogeneous antibody‐drug conjugates. |
doi_str_mv | 10.1002/anie.202000062 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2377344350</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2412793940</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4102-15dff5735d01822bbd862af130c1377612b975ddb2434137b5d2b94e1b45f96c3</originalsourceid><addsrcrecordid>eNqFkb1OIzEYRS3ECligpUQj0dBM8O_8lChkdyOFgBSoLXv8DRhNbBhPWEU0PALPyJOsh2SDRIMbW1fnO7J9EToieEAwpmfKWRhQTHFcGd1Ce0RQkrI8Z9vxzBlL80KQXfQzhIfIFwXOdtAuoyQnmIs99DK8h7kP0EDV2WdIlDPJzHbw_vo224STZbCujy5sGyMw6yS59MbWtlKd9S4ZOaUbCHHc3TUfguhJJkpDE5PE18lUfeiuW9-BdeEA_ahVE-Bwve-j21-jm-GfdHL1ezw8n6QVJ5imRJi6FjkTBpOCUq1NkVFVE4YrEh-aEarLXBijKWc8JlqYmHAgmou6zCq2j05X3sfWPy0gdHJuQwVNoxz4RZC0_y7OmcARPfmCPvhF6-LtJOWE5iUreU8NVlTV-hBaqOVja-eqXUqCZV-L7GuRm1riwPFau9BzMBv8fw8RKFfAX9vA8hudPJ-OR5_yfy1Sm-Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2412793940</pqid></control><display><type>article</type><title>Chemoselective and Site‐Selective Lysine‐Directed Lysine Modification Enables Single‐Site Labeling of Native Proteins</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Adusumalli, Srinivasa Rao ; Rawale, Dattatraya Gautam ; Thakur, Kalyani ; Purushottam, Landa ; Reddy, Neelesh C. ; Kalra, Neetu ; Shukla, Sanjeev ; Rai, Vishal</creator><creatorcontrib>Adusumalli, Srinivasa Rao ; Rawale, Dattatraya Gautam ; Thakur, Kalyani ; Purushottam, Landa ; Reddy, Neelesh C. ; Kalra, Neetu ; Shukla, Sanjeev ; Rai, Vishal</creatorcontrib><description>The necessity for precision labeling of proteins emerged during the efforts to understand and regulate their structure and function. It demands selective attachment of tags such as affinity probes, fluorophores, and potent cytotoxins. Here, we report a method that enables single‐site labeling of a high‐frequency Lys residue in the native proteins. At first, the enabling reagent forms stabilized imines with multiple solvent‐accessible Lys residues chemoselectively. These linchpins create the opportunity to regulate the position of a second Lys‐selective electrophile connected by a spacer. Consequently, it enables the irreversible single‐site labeling of a Lys residue independent of its place in the reactivity order. The user‐friendly protocol involves a series of steps to deconvolute and address chemoselectivity, site‐selectivity, and modularity. Also, it delivers ordered immobilization and analytically pure probe‐tagged proteins. Besides, the methodology provides access to antibody‐drug conjugate (ADC), which exhibits highly selective anti‐proliferative activity towards HER‐2 expressing SKBR‐3 breast cancer cells.
A chemical methodology finally addresses the undefeated challenge of modular and precision engineering of a Lys residue in a native protein. The remarkable control over selectivity provides the first‐ever approach to target Lys beyond the protein‐defined reactivity hotspot. This technology unfolds new gateways and renders analytically pure protein bioconjugates and homogeneous antibody‐drug conjugates.</description><edition>International ed. in English</edition><identifier>ISSN: 1433-7851</identifier><identifier>EISSN: 1521-3773</identifier><identifier>DOI: 10.1002/anie.202000062</identifier><identifier>PMID: 32171045</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Antibodies ; antibody-drug conjugate ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; bioconjugation ; Breast cancer ; Cell Line, Tumor ; Chemical compounds ; Cytotoxins ; Drug Screening Assays, Antitumor ; Fluorescence ; Fluorescent Dyes - chemistry ; Fluorophores ; Humans ; Imines ; Immobilization ; Indicators and Reagents - chemistry ; Labeling ; Lysine ; Lysine - analogs & derivatives ; lysine labeling ; Maytansine - chemistry ; Maytansine - pharmacology ; Modularity ; protein modification ; Proteins ; Proteins - chemistry ; Reagents ; Residues ; Selectivity ; Structure-function relationships ; Trastuzumab - chemistry</subject><ispartof>Angewandte Chemie International Edition, 2020-06, Vol.59 (26), p.10332-10336</ispartof><rights>2020 Wiley‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><rights>2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4102-15dff5735d01822bbd862af130c1377612b975ddb2434137b5d2b94e1b45f96c3</citedby><cites>FETCH-LOGICAL-c4102-15dff5735d01822bbd862af130c1377612b975ddb2434137b5d2b94e1b45f96c3</cites><orcidid>0000-0003-3361-0588 ; 0000-0001-6263-7072 ; 0000-0002-6078-3516 ; 0000-0002-1448-5737 ; 0000-0001-6859-6451 ; 0000-0001-8856-3278 ; 0000-0002-8335-0641 ; 0000-0001-7504-8787</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fanie.202000062$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fanie.202000062$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32171045$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adusumalli, Srinivasa Rao</creatorcontrib><creatorcontrib>Rawale, Dattatraya Gautam</creatorcontrib><creatorcontrib>Thakur, Kalyani</creatorcontrib><creatorcontrib>Purushottam, Landa</creatorcontrib><creatorcontrib>Reddy, Neelesh C.</creatorcontrib><creatorcontrib>Kalra, Neetu</creatorcontrib><creatorcontrib>Shukla, Sanjeev</creatorcontrib><creatorcontrib>Rai, Vishal</creatorcontrib><title>Chemoselective and Site‐Selective Lysine‐Directed Lysine Modification Enables Single‐Site Labeling of Native Proteins</title><title>Angewandte Chemie International Edition</title><addtitle>Angew Chem Int Ed Engl</addtitle><description>The necessity for precision labeling of proteins emerged during the efforts to understand and regulate their structure and function. It demands selective attachment of tags such as affinity probes, fluorophores, and potent cytotoxins. Here, we report a method that enables single‐site labeling of a high‐frequency Lys residue in the native proteins. At first, the enabling reagent forms stabilized imines with multiple solvent‐accessible Lys residues chemoselectively. These linchpins create the opportunity to regulate the position of a second Lys‐selective electrophile connected by a spacer. Consequently, it enables the irreversible single‐site labeling of a Lys residue independent of its place in the reactivity order. The user‐friendly protocol involves a series of steps to deconvolute and address chemoselectivity, site‐selectivity, and modularity. Also, it delivers ordered immobilization and analytically pure probe‐tagged proteins. Besides, the methodology provides access to antibody‐drug conjugate (ADC), which exhibits highly selective anti‐proliferative activity towards HER‐2 expressing SKBR‐3 breast cancer cells.
A chemical methodology finally addresses the undefeated challenge of modular and precision engineering of a Lys residue in a native protein. The remarkable control over selectivity provides the first‐ever approach to target Lys beyond the protein‐defined reactivity hotspot. This technology unfolds new gateways and renders analytically pure protein bioconjugates and homogeneous antibody‐drug conjugates.</description><subject>Antibodies</subject><subject>antibody-drug conjugate</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>bioconjugation</subject><subject>Breast cancer</subject><subject>Cell Line, Tumor</subject><subject>Chemical compounds</subject><subject>Cytotoxins</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Fluorescence</subject><subject>Fluorescent Dyes - chemistry</subject><subject>Fluorophores</subject><subject>Humans</subject><subject>Imines</subject><subject>Immobilization</subject><subject>Indicators and Reagents - chemistry</subject><subject>Labeling</subject><subject>Lysine</subject><subject>Lysine - analogs & derivatives</subject><subject>lysine labeling</subject><subject>Maytansine - chemistry</subject><subject>Maytansine - pharmacology</subject><subject>Modularity</subject><subject>protein modification</subject><subject>Proteins</subject><subject>Proteins - chemistry</subject><subject>Reagents</subject><subject>Residues</subject><subject>Selectivity</subject><subject>Structure-function relationships</subject><subject>Trastuzumab - chemistry</subject><issn>1433-7851</issn><issn>1521-3773</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkb1OIzEYRS3ECligpUQj0dBM8O_8lChkdyOFgBSoLXv8DRhNbBhPWEU0PALPyJOsh2SDRIMbW1fnO7J9EToieEAwpmfKWRhQTHFcGd1Ce0RQkrI8Z9vxzBlL80KQXfQzhIfIFwXOdtAuoyQnmIs99DK8h7kP0EDV2WdIlDPJzHbw_vo224STZbCujy5sGyMw6yS59MbWtlKd9S4ZOaUbCHHc3TUfguhJJkpDE5PE18lUfeiuW9-BdeEA_ahVE-Bwve-j21-jm-GfdHL1ezw8n6QVJ5imRJi6FjkTBpOCUq1NkVFVE4YrEh-aEarLXBijKWc8JlqYmHAgmou6zCq2j05X3sfWPy0gdHJuQwVNoxz4RZC0_y7OmcARPfmCPvhF6-LtJOWE5iUreU8NVlTV-hBaqOVja-eqXUqCZV-L7GuRm1riwPFau9BzMBv8fw8RKFfAX9vA8hudPJ-OR5_yfy1Sm-Q</recordid><startdate>20200622</startdate><enddate>20200622</enddate><creator>Adusumalli, Srinivasa Rao</creator><creator>Rawale, Dattatraya Gautam</creator><creator>Thakur, Kalyani</creator><creator>Purushottam, Landa</creator><creator>Reddy, Neelesh C.</creator><creator>Kalra, Neetu</creator><creator>Shukla, Sanjeev</creator><creator>Rai, Vishal</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3361-0588</orcidid><orcidid>https://orcid.org/0000-0001-6263-7072</orcidid><orcidid>https://orcid.org/0000-0002-6078-3516</orcidid><orcidid>https://orcid.org/0000-0002-1448-5737</orcidid><orcidid>https://orcid.org/0000-0001-6859-6451</orcidid><orcidid>https://orcid.org/0000-0001-8856-3278</orcidid><orcidid>https://orcid.org/0000-0002-8335-0641</orcidid><orcidid>https://orcid.org/0000-0001-7504-8787</orcidid></search><sort><creationdate>20200622</creationdate><title>Chemoselective and Site‐Selective Lysine‐Directed Lysine Modification Enables Single‐Site Labeling of Native Proteins</title><author>Adusumalli, Srinivasa Rao ; Rawale, Dattatraya Gautam ; Thakur, Kalyani ; Purushottam, Landa ; Reddy, Neelesh C. ; Kalra, Neetu ; Shukla, Sanjeev ; Rai, Vishal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4102-15dff5735d01822bbd862af130c1377612b975ddb2434137b5d2b94e1b45f96c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibodies</topic><topic>antibody-drug conjugate</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>bioconjugation</topic><topic>Breast cancer</topic><topic>Cell Line, Tumor</topic><topic>Chemical compounds</topic><topic>Cytotoxins</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Fluorescence</topic><topic>Fluorescent Dyes - chemistry</topic><topic>Fluorophores</topic><topic>Humans</topic><topic>Imines</topic><topic>Immobilization</topic><topic>Indicators and Reagents - chemistry</topic><topic>Labeling</topic><topic>Lysine</topic><topic>Lysine - analogs & derivatives</topic><topic>lysine labeling</topic><topic>Maytansine - chemistry</topic><topic>Maytansine - pharmacology</topic><topic>Modularity</topic><topic>protein modification</topic><topic>Proteins</topic><topic>Proteins - chemistry</topic><topic>Reagents</topic><topic>Residues</topic><topic>Selectivity</topic><topic>Structure-function relationships</topic><topic>Trastuzumab - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adusumalli, Srinivasa Rao</creatorcontrib><creatorcontrib>Rawale, Dattatraya Gautam</creatorcontrib><creatorcontrib>Thakur, Kalyani</creatorcontrib><creatorcontrib>Purushottam, Landa</creatorcontrib><creatorcontrib>Reddy, Neelesh C.</creatorcontrib><creatorcontrib>Kalra, Neetu</creatorcontrib><creatorcontrib>Shukla, Sanjeev</creatorcontrib><creatorcontrib>Rai, Vishal</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Angewandte Chemie International Edition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adusumalli, Srinivasa Rao</au><au>Rawale, Dattatraya Gautam</au><au>Thakur, Kalyani</au><au>Purushottam, Landa</au><au>Reddy, Neelesh C.</au><au>Kalra, Neetu</au><au>Shukla, Sanjeev</au><au>Rai, Vishal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemoselective and Site‐Selective Lysine‐Directed Lysine Modification Enables Single‐Site Labeling of Native Proteins</atitle><jtitle>Angewandte Chemie International Edition</jtitle><addtitle>Angew Chem Int Ed Engl</addtitle><date>2020-06-22</date><risdate>2020</risdate><volume>59</volume><issue>26</issue><spage>10332</spage><epage>10336</epage><pages>10332-10336</pages><issn>1433-7851</issn><eissn>1521-3773</eissn><abstract>The necessity for precision labeling of proteins emerged during the efforts to understand and regulate their structure and function. It demands selective attachment of tags such as affinity probes, fluorophores, and potent cytotoxins. Here, we report a method that enables single‐site labeling of a high‐frequency Lys residue in the native proteins. At first, the enabling reagent forms stabilized imines with multiple solvent‐accessible Lys residues chemoselectively. These linchpins create the opportunity to regulate the position of a second Lys‐selective electrophile connected by a spacer. Consequently, it enables the irreversible single‐site labeling of a Lys residue independent of its place in the reactivity order. The user‐friendly protocol involves a series of steps to deconvolute and address chemoselectivity, site‐selectivity, and modularity. Also, it delivers ordered immobilization and analytically pure probe‐tagged proteins. Besides, the methodology provides access to antibody‐drug conjugate (ADC), which exhibits highly selective anti‐proliferative activity towards HER‐2 expressing SKBR‐3 breast cancer cells.
A chemical methodology finally addresses the undefeated challenge of modular and precision engineering of a Lys residue in a native protein. The remarkable control over selectivity provides the first‐ever approach to target Lys beyond the protein‐defined reactivity hotspot. This technology unfolds new gateways and renders analytically pure protein bioconjugates and homogeneous antibody‐drug conjugates.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32171045</pmid><doi>10.1002/anie.202000062</doi><tpages>5</tpages><edition>International ed. in English</edition><orcidid>https://orcid.org/0000-0003-3361-0588</orcidid><orcidid>https://orcid.org/0000-0001-6263-7072</orcidid><orcidid>https://orcid.org/0000-0002-6078-3516</orcidid><orcidid>https://orcid.org/0000-0002-1448-5737</orcidid><orcidid>https://orcid.org/0000-0001-6859-6451</orcidid><orcidid>https://orcid.org/0000-0001-8856-3278</orcidid><orcidid>https://orcid.org/0000-0002-8335-0641</orcidid><orcidid>https://orcid.org/0000-0001-7504-8787</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1433-7851 |
ispartof | Angewandte Chemie International Edition, 2020-06, Vol.59 (26), p.10332-10336 |
issn | 1433-7851 1521-3773 |
language | eng |
recordid | cdi_proquest_miscellaneous_2377344350 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Antibodies antibody-drug conjugate Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology bioconjugation Breast cancer Cell Line, Tumor Chemical compounds Cytotoxins Drug Screening Assays, Antitumor Fluorescence Fluorescent Dyes - chemistry Fluorophores Humans Imines Immobilization Indicators and Reagents - chemistry Labeling Lysine Lysine - analogs & derivatives lysine labeling Maytansine - chemistry Maytansine - pharmacology Modularity protein modification Proteins Proteins - chemistry Reagents Residues Selectivity Structure-function relationships Trastuzumab - chemistry |
title | Chemoselective and Site‐Selective Lysine‐Directed Lysine Modification Enables Single‐Site Labeling of Native Proteins |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T08%3A14%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemoselective%20and%20Site%E2%80%90Selective%20Lysine%E2%80%90Directed%20Lysine%20Modification%20Enables%20Single%E2%80%90Site%20Labeling%20of%20Native%20Proteins&rft.jtitle=Angewandte%20Chemie%20International%20Edition&rft.au=Adusumalli,%20Srinivasa%20Rao&rft.date=2020-06-22&rft.volume=59&rft.issue=26&rft.spage=10332&rft.epage=10336&rft.pages=10332-10336&rft.issn=1433-7851&rft.eissn=1521-3773&rft_id=info:doi/10.1002/anie.202000062&rft_dat=%3Cproquest_cross%3E2412793940%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2412793940&rft_id=info:pmid/32171045&rfr_iscdi=true |